Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1756530 | 0.95 | CES2 (0.38) | CES2CES1MEN1ALDH1A1LMNA | |
| SCHEMBL1756501 | 0.95 | CES2 (0.38) | CES2CES1 | |
| SCHEMBL219009 | 0.86 | CES2 (0.38) | CES2CES1 | |
| SCHEMBL1756500 | 0.86 | CES2 (0.38) | CES2CES1MEN1ALDH1A1LMNA | |
| SCHEMBL7214722 | 0.86 | CES2 (0.38) | CES2CES1 | |
| SCHEMBL1942159 | 0.82 | CES2 (0.36) | CES2CES1 | |
| Magnesium SCHEMBL30578300 | 0.82 | CES2 (0.36) | CES2CES1 | |
| SCHEMBL10589276 | 0.82 | CES2 (0.36) | CES2CES1 | |
| SCHEMBL4449502 | 0.82 | CES2 (0.36) | CES2CES1MEN1ALDH1A1LMNA | |
| SCHEMBL4345041 | 0.80 | CES2 (0.33) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0944564-B9 | HALOGEN EXCHANGE REACTIONS AND USES THEREOF | ALBEMARLE CORP (US) | 2005-01-19 | — | — | EP | claimed |
| EP-0944564-B1 | HALOGEN EXCHANGE REACTIONS AND USES THEREOF | ALBEMARLE CORP (US) | 2002-03-20 | — | — | EP | claimed |
| EP-0944564-A1 | HALOGEN EXCHANGE REACTIONS AND USES THEREOF | ALBEMARLE CORPORATION (US) | 1999-09-29 | — | — | EP | claimed |
| US-5824827-A | Halogen exchange reactions | ALBEMARLE CORPORATION (US) | 1998-10-20 | — | — | US | claimed |
| WO-1998022413-A1 | HALOGEN EXCHANGE REACTIONS AND USES THEREOF | ALBEMARLE CORPORATION (US) | 1998-05-28 | — | — | WO | claimed |
| CN-119137244-A | Lubricant for magnetic recording medium | 株式会社力森诺科 | 2024-12-13 | — | — | CN | disclosed |
| US-20240409489-A1 | METHOD FOR PRODUCING FLUORINATED POLYETHER | RESONAC CORPORATION (JP) | 2024-12-12 | — | — | US | disclosed |
| US-20240400757-A1 | METHOD FOR PRODUCING FLUORINATED POLYETHER | RESONAC CORPORATION (JP) | 2024-12-05 | — | — | US | disclosed |
| WO-2024214529-A1 | MAGNETIC RECORDING MEDIUM LUBRICANT | 株式会社レゾナック | 2024-10-17 | — | — | WO | disclosed |
| CN-118139839-A | Process for producing fluorinated polyether | 株式会社力森诺科 | 2024-06-04 | — | — | CN | disclosed |
| CN-118055920-A | Process for producing fluorinated polyether | 株式会社力森诺科 | 2024-05-17 | — | — | CN | disclosed |
| WO-2023058753-A1 | METHOD FOR PRODUCING FLUORINATED POLYETHER | 株式会社レゾナック | 2023-04-13 | — | — | WO | disclosed |
| US-5744678-A | NICKEL COMPOUND, ORGANOPHOSPHORUS COMPOUND, ORGANOALUMINUM COMPOUND, CARBON-HALOGEN COMPOUNDS; CATALYST SELECTIVITY | NIPPON OIL CO., LTD. (JP) | 1998-04-28 | — | — | US | disclosed |
| US-5728641-A | Catalyst component for the polymerization of olefins | NIPPON OIL COMPANY, LIMITED (JP) | 1998-03-17 | — | — | US | disclosed |
| EP-0758563-A1 | OLEFIN OLIGOMERIZATION CATALYST AND PROCESS FOR THE PREPARATION OF OLEFIN OLIGOMER USING IT | NIPPON OIL COMPANY, LTD. (JP) | 1997-02-19 | — | — | EP | disclosed |
| US-5556821-A | Catalyst component for the polymerization of olefins | NIPPON OIL COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0587440-A2 | Catalyst component for the polymerisation of olefins and process for preparing olefin polymers using same | NIPPON OIL COMPANY, LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
| US-4734503-A | Catalytic transhalogenation of haloaromatics | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-03-29 | — | — | US | disclosed |
| EP-0233035-A1 | Catalytic transhalogenation of haloaromatics | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-08-19 | — | — | EP | disclosed |
| US-4680406-A | Process for fluorinating halogenated organo-compounds | THE DOW CHEMICAL COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409489-A1 | METHOD FOR PRODUCING FLUORINATED POLYETHER | MRPL21, RPS4X, MLX | CES2 3421/4885CES1 3032/4885MEN1 721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.